Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools ACC

ACC

Programs, trials, and reported response and survival for adenoid cystic carcinoma.

Data as of 11.07.2026

All studies

LUTETIUM-177 PSMA Radioligand

LUPSA

Radboud UMC; Johns Hopkins (investigators) · Phase 2 · Completed · Enrollment 12

NCT04291300

ArmPopulationDoseEstimandComparatorEfficacy

No efficacy figure is in this file for this study.